✦ LIBER ✦

Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors

✍ Scribed by Laura L. Jung; Ramesh K. Ramanathan; Merrill J. Egorin; Ruzhi Jin; Chandra P. Belani; Douglas M. Potter; Sandra Strychor; Donald L. Trump; Christine Walko; Marwan Fakih; William C. Zamboni

Publisher: Springer
Year: 2004
Tongue: English
Weight: 263 KB
Volume: 54
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0835-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I pharmacokinetics study of 9-ni

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

✍ Zhao Yan; Zhongling Zhu; Kai Li; Peng Chen; Liuchun Wang; Chun Huang; Jinhuai Xu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 209 KB

Clinical and pharmacokinetic study evalu

Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors

✍ William C. Zamboni; Sanjay Goel; Tahir Iqbal; Robert A. Parise; Sandra Strychor; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 278 KB

A Phase I study of 9-nitrocamptothecin g

A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors

✍ M. Dror Michaelson; David P. Ryan; Charles S. Fuchs; Jeffrey G. Supko; Rocio Gar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract ## BACKGROUND 9‐Nitrocamptothecin (9‐NC) is an orally available camptothecin analog with antineoplastic activity that results from the inhibition of DNA topoisomerase I. Previous studies have suggested that it has significant clinical efficacy. The primary toxicities of 9‐NC include ga

Pharmacokinetics and toxicity of 120-hou

Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors

✍ E. M. Newman; Mary Carroll; Steven A. Akman; Warren Chow; P. Coluzzi; Victor Ham 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 118 KB

Phase I and pharmacokinetic trial of car

Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors

✍ Thomas E. Stinchcombe; Mark A. Socinski; Christine M. Walko; Bert H. O’Neil; Fra 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 388 KB

Phase I study to determine the safety an

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors

✍ David S. Hong; James L. Abbruzzese; Karla Bogaard; Yvonne Lassere; Masakazu Fuku 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views